EUVIMEDEUVIMED entdecken
Crossref

L26/P-112 Cumulus cell CDC20 expression as a potential intra-patient molecular marker for predicting human oocyte developmental competence using sibling oocyte comparisons

Y. Kai, H. Fukushima, A. Inoue, N. Yamashita

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Kai und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can a within-patient paired transcriptomic comparison of sibling cumulus cells identify a robust molecular marker of oocyte developmental competence while minimizing inter-patient variability? Summary answer CDC20 expression was higher in cumulus cells from low-competence sibling oocytes in most patients, supporting its utility as a reproducible intra-patient molecular marker. What is known already Oocyte developmental competence is shaped by the follicular microenvironment, and cumulus cells (CCs) mirror transcriptional programs essential for maturation and early development. Numerous CC-derived molecular markers have been proposed, but reproducibility has remained limited because substantial inter-patient variability often obscures subtle yet biologically relevant signals. Intra-patient paired analysis—comparing CCs from different sibling oocytes within the same stimulation cycle—offers a powerful strategy to minimize this variability and improve signal detection. Identifying robust markers through such paired approaches could refine prediction of developmental competence and support clinical prioritization, particularly in IVF and fertility preservation settings. Study design, size, duration This study employed a sibling-based intra-patient paired design using cumulus cell–oocyte complexes collected within the same stimulation cycle to minimize inter-individual variability. In the discovery phase, RNA-seq was conducted on seven CC pairs from five patients. In the validation phase, twelve CC pairs from twelve patients were analyzed using RT-qPCR. All cycles yielded at least two mature oocytes, enabling patient-specific comparison of high- and low-competence sibling oocytes. Participants/materials, setting, methods Cumulus cells were mechanically isolated at denudation and individually cryopreserved. Oocytes underwent conventional IVF. Developmental competence was defined according to established criteria: high-competence oocytes resulted in clinically confirmed pregnancy defined as gestational sac detection (GS), or formed blastocysts ≥170 μm by < 130 h according to our published criteria (Kai et al., 2022). Low-competence oocytes failed to form blastocysts. Six RNA-seq–derived candidates were validated by paired RT-qPCR using ACTB. Main results and the role of chance RNA-seq of seven sibling cumulus cell (CC) pairs identified several genes associated with oocyte developmental competence, from which six candidates (HILPDA, UBE2C, CDK1, TOP2A, CDC20, and PBK) were selected for validation. In the RT-qPCR validation set of twelve sibling pairs, CDC20 was the only gene that demonstrated a reproducible paired difference. CDC20 expression was higher in CCs attached to low-competence oocytes in 10 of 12 patients, indicating a strong directionality of change despite two discordant cases. The overall paired comparison was statistically significant (paired t-test p < 0.05), supported by a meaningful effect size (Cohen’s d > 0.5) and 95% confidence intervals not crossing zero, underscoring the robustness of the association. The remaining genes showed inconsistent paired differences and were not pursued further. Among the twelve patients, seven underwent embryo transfer and six achieved clinical pregnancy, supporting the accuracy of the competence classification. Overall, these findings demonstrate that CDC20 downregulation in sibling cumulus cells represents a reproducible, patient-specific molecular signature predictive of human oocyte developmental competence, underscoring its potential utility in oocyte prioritization across IVF and fertility preservation. Limitations, reasons for caution The sample size was limited, particularly in the discovery phase. Although functional assays were not performed, CDC20’s established role in cell-cycle regulation provides a plausible mechanistic link to oocyte competence. Validation in larger and more diverse patient groups will be required before clinical translation. Wider implications of the findings CDC20 downregulation in sibling cumulus cells may serve as a predictive marker of oocyte developmental competence and support oocyte prioritization, particularly in fertility preservation. The sibling-based intra-patient approach enhances biomarker discovery by improving signal detection beyond conventional inter-patient comparisons. Trial registration number No

Zitieren

APA

Kai, Y., Fukushima, H., Inoue, A., & Yamashita, N. (2026). L26/P-112 Cumulus cell CDC20 expression as a potential intra-patient molecular marker for predicting human oocyte developmental competence using sibling oocyte comparisons. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.448

Vancouver

Kai Y, Fukushima H, Inoue A, Yamashita N. L26/P-112 Cumulus cell CDC20 expression as a potential intra-patient molecular marker for predicting human oocyte developmental competence using sibling oocyte comparisons. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.448

BibTeX
@article{Kai2026,
  author = {Kai, Y. and Fukushima, H. and Inoue, A. and Yamashita, N.},
  title = {L26/P-112 Cumulus cell CDC20 expression as a potential intra-patient molecular marker for predicting human oocyte developmental competence using sibling oocyte comparisons},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.448}
}
Kostenlos starten →